Key Points
Summary
Johnson & Johnson (J&J) announced its fourth-quarter results, surpassing Wall Street's expectations with strong sales from its cancer treatments, particularly Darzalex, which saw a 20.9% increase year-over-year. The company has been aggressively expanding through acquisitions, highlighted by the recent $14.6 billion purchase of Intra-Cellular, aimed at bolstering its psychiatric drug offerings. Despite these positive developments, J&J's shares fell 1.5% in premarket trading due to a higher-than-expected negative impact from foreign currency, which was described as a "negative surprise" by investors. For 2025, J&J anticipates sales between $90.9 billion and $91.7 billion, with earnings per share expected to be between $10.75 and $10.95, excluding the effects of the Intra-Cellular deal and currency fluctuations. The company's innovative medicine and medtech units both showed growth, although sales of its psoriasis treatment Stelara declined due to the introduction of biosimilars in various markets. Overall, J&J's strategic acquisitions and robust performance in key drug sectors continue to shape its market position, despite some investor skepticism regarding future growth targets.
Key Points
Summary
The U.S. housing market, already strained by high mortgage rates, low inventory, and soaring home prices, faces further challenges due to new tariffs on building materials. President Trump's 25% tariffs on goods from Canada and Mexico, key suppliers of softwood lumber and gypsum respectively, are set to increase construction costs significantly. The NAHB has highlighted that these tariffs could add $3 to $4 billion to construction costs, potentially pushing up home prices and making housing less affordable, particularly for first-time buyers. Despite a slight delay in the implementation of tariffs on Mexican goods, the threat of increased costs remains. The situation is compounded by a labor shortage in construction, exacerbated by immigration policies, and the potential for rising interest rates if inflation increases due to these tariffs. This could severely impact the spring housing market, affecting both new construction and the existing home market as potential buyers might have less disposable income for down payments.
Key Points
Summary
The concept of retirement is undergoing a transformation, particularly among millennials who are increasingly prioritizing living in the moment over traditional retirement goals. According to Michael Liersch from Wells Fargo, the focus has shifted from the end goal of retirement to enjoying life now. A 2024 report by Edelman Financial Engines highlights that 37% of Americans envision a retirement different from past generations, with many desiring an active and adventurous lifestyle, and 32% believing they will never fully retire. Despite their financial growth, with the median wealth of younger generations quadrupling and a 400% increase in seven-figure retirement accounts, millennials face immediate financial pressures like student loans, housing, and child care costs. This shift in priorities reflects a broader change in how younger generations view work and retirement, moving away from the traditional notion of stopping work entirely to seeking flexibility and the ability to choose their work in later years.
Key Points
Summary
Amundi, Europe's leading fund manager, announced that its quarterly inflows met expectations, driven by a robust demand for risk-averse investment products. In the last quarter of the year, the company saw net inflows of 20.5 billion euros, which helped push its total assets under management to a record 2.24 trillion euros, marking a 10% increase from the previous year. Notably, there was a significant influx into safe investment options like medium and long-term assets through ETFs and ETCs, with these products alone bringing in 10.5 billion euros in net inflows. This surge led to a 30% increase in ETF AUM, reaching 268 billion euros. CEO Valerie Baudson highlighted Amundi's strategic position in the market, expressing openness to acquisitions and noting the company's role as a potential consolidator in the industry. Amundi's financial performance was strong, with a 20.5% rise in adjusted net income to 377 million euros, surpassing analyst expectations. The company also achieved its 2025 strategic goals a year early, reflecting confidence in its future growth and market position.
